Neurocrine Biosciences Inc (NBIX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Finanzdaten der Neurocrine Biosciences Inc-Aktie (NBIX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	20.07% 687.50	572.60	622.10	590.20	515.30
Cost Of Revenue	22.83% 11.30	9.20	8.00	9.20	7.50
Gross Profit	20.02% 676.20	563.40	614.10	581.00	507.80
Operating Expenses	1.70% 530.60	539.80	430.30	435.60	408.50
Benefits Costs and Expenses	5.36% 528.00	557.90	431.80	491.60	480.80
Costs And Expenses	1.29% 541.90	549.00	438.30	444.80	416.00
Operating Income/Loss	516.95% 145.60	23.60	183.80	145.40	99.30
Nonoperating Income/Loss	256.18% 13.90	-8.90	6.50	-46.80	-64.80
Income/Loss From Continuing Operations Before Tax	985.03% 159.50	14.70	190.30	98.60	34.50
Income Tax Expense/Benefit	664.71% 52.00	6.80	60.50	33.60	-8.90
Income/Loss From Continuing Operations After Tax	1,261% 107.50	7.90	129.80	65.00	43.40
Net Income/Loss	1,261% 107.50	7.90	129.80	65.00	43.40
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.70% 99.00	99.70	101.10	100.80	99.80
Diluted Average Shares	1.46% 101.00	102.50	104.30	103.90	103.60
Basic Earnings Per Share	1,262% 1.09	0.08	1.28	0.64	0.43
Diluted Earnings Per Share	1,225% 1.06	0.08	1.24	0.63	0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

UTHR

$305.35

1.25%

VTRS

$10.42

0.10%

RDY

$14.24

0.21%

ELAN

$18.49

3.30%

TEVA

$18.05

0.55%